Medpace Holdings, Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
58506Q109
SEDOL
BDCBC61
CIK
0001668397
www.medpace.com
LEI:
©
FIGI: BBG0065B7K59
MEDP
Medpace Holdings, Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Diagnostics & Research
AI
PROFILER
NAME
Medpace Holdings, Inc.
ISIN
US58506Q1094
TICKER
MEDP
MIC
XNAS
REUTERS
MEDP.OQ
BLOOMBERG
MEDP US
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
GIF DE 728x90
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Do., 02.01.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2024 financial results after the market close on Monday, February 10, 2025. The Company will host a conference call the following morning, Tuesday, February 11, 2025, at 9:00 a.m. ET to discuss these results. To participate in...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
Fr., 08.11.2024       Medpace
US58506Q1094

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
Do., 31.10.2024       Medpace
US58506Q1094

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
Mi., 23.10.2024       Medpace
US58506Q1094

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed t...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
Mi., 23.10.2024       Medpace
US58506Q1094

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) (“Medpace”). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its reve...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
Mo., 21.10.2024       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results Revenue for the three months ended September 30, 2024 increased 8.3% to $533.3 million, compared to $492.5 million for the comparable prior-year period. On a constant currency ba...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
Di., 08.10.2024       Medpace
US58506Q1094

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
Mo., 30.09.2024       Medpace
US58506Q1094

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.co...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
Di., 24.09.2024       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2024 financial results after the market close on Monday, October 21, 2024. The Company will host a conference call the following morning, Tuesday, October 22, 2024, at 9:00 a.m. ET to discuss these results. To participate in the conference call...
weiterlesen
Medpace
Research & Analysen Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S